ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer.

Yinu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.